Interferon- ζ/Limitin: Novel Type I Interferon That Displays a Narrow Range of Biological Activity

  title={Interferon- $\zeta$/Limitin: Novel Type I Interferon That Displays a Narrow Range of Biological Activity},
  author={Kenji Oritani and Yoshiaki Tomiyama},
  journal={International Journal of Hematology},
Interferon ζ (IFN-ζ)/limitin has been regarded as a novel type IIFN by the Nomenclature Committee of the International Society for Interferon and Cytokine Research. IFN-ζ/limitin, which has some sequence homology with IFN-α and IFN-ß, has a globular structure with 5 α helices and 4 loops and recognizes IFN-α/ß receptor. Although it displays antiviral, immunomodulatory, and antitumor effects, IFN-ζ/limitin has much less lymphomyelosuppressive activity than IFN-α. Unique interactions between IFN… 

IFN‐ζ limitin: a member of type I IFN with mild lympho‐myelosuppression

Although IFN‐ζlimitin displays antiviral, immunomodulatory, and antitumor effects, it has much less lymphomyelosuppressive activities thanIFN‐α, and little ability of IFN'ζ limitin to activate the Tyk2‐dependent signaling pathway may explain its uniquely narrow range of biological activities.

Interferons : between structure and function

A high level of antiviral protection is achieved byIFN-α, IFN-β and IFN -λ, which act on receptors formed by λR1 IFN and IL-10R2 subunits.

Interferons as Immune Regulators: A Rivalry between HCV and Interferons

The pharmacodynamics of IFNs are described with an aim to decipher the possible involvement of HCV proteins in subverting these responses, since they have a strong impact in determining the efficacy of an IFN in HCV infected host.

Interferon‐λs: the modulators of antivirus, antitumor, and immune responses

Recent findings about the biology of IFN‐λs and their pathophysiological roles in viral infection, cancer, and immune responses of the innate and adaptive arms are summarized.

Cloning and characterization of porcine interferon-δ-related genes identified by genomic database screening.

Among all the PoIFN-δ subtypes detected, PoIFn- δ8 has the strongest antiviral and immunomodulatory activities.

Chloroplast-based Overexpression Of Pharmaceuticals To Develop Cost-effective Therapeutics

It was experienced that mature leaves contained high levels interferon compared to young and senescence leaves, and transplastomic technology is the best choice, now days, to overexpress pharmaceuticals cost-effectively.

Macrophages and cytokines in the early defence against herpes simplex virus

Many positive feed-back mechanisms and synergistic interactions intensify these systems and give rise to heavy antiviral weapons such as reactive oxygen species and nitric oxide which results in the generation of an alliance against the viral enemy.

Herpes Simplex Virus Evasion of Early Host Antiviral Responses

A comprehensive understanding of how HSVs evade host early antiviral responses could contribute to the development of novel therapies and vaccines to counteract these viruses.



Type I interferons and limitin: a comparison of structures, receptors, and functions.

Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis*

The structural basis for functional differences in α and β interferon subtypes is defined and a subset of these latter mutations did reduce activity in a manner analogous to IFN-α mutations.

Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha.

Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

Recent developments in the understanding of the antiviral and immunoregulatory properties of IFN-alpha, the nature of the multisubunit IFn-alpha receptor, and the molecular mechanisms of signal transduction are reviewed.

Characterization of N-Terminal Interferon τ Mutants: P26L Affords Enhanced Activity and Lack of Toxicity

The structural basis for the activity of type I IFNs was examined, focusing on amino acids within helix A and the first section of the AB loop, which have been proposed as a site for receptor interaction, and the IFN- τ P26L mutant may have potential as an improvedIFN-based therapeutic.

Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes*

Interferon-κ therefore defines a novel subclass of type I interferon that is expressed in keratinocytes and expands the repertoire of known proteins mediating host defense.

IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex

The identification of a ligand-receptor system that, upon engagement, leads to the establishment of an antiviral state and may contribute to antiviral or other defenses by a mechanism similar to, but independent of, type I IFNs.

Ligand-induced association of the type I interferon receptor components

Cross-linking shows that IFNAR and IFN-alpha/beta R are components of a common type I IFN receptor, cooperating in ligand binding, and probably triggers transmembrane signaling.

New aspects of IFN‐α/β signalling in immunity, oncogenesis and bone metabolism

This review focuses on the newly discovered roles of the IFN‐α/β system in host defense and bone remodeling, particularly on the functions of the weakIFN‐ α/β signalling in the context of what is referred to as the “rewing‐up” model.